
Track health easily with the best blood pressure monitors
Knowing your blood pressure is an essential tool in managing your overall health. Many people only visit their doctor once or twice a year, which may allow potential problems to go unnoticed and undiagnosed for months. Getting your blood pressure taken is also stressful, which can result in a higher than usual reading when taken at your physician's office.
Home blood pressure monitors allow you to take control of your health in a place where you feel relaxed and comfortable. The top pick, the Withings BPM Connect Blood Pressure Monitor, will even email your results directly to your doctor.
Wrist vs. upper arm blood pressure monitors
Home blood pressure monitors are available in wrist or upper arm models. Upper arm monitors are what you'll find at your doctor's office. The upside to wrist monitors is that they're wireless, portable and smaller, as they simply wrap around your wrist. You can keep an extra on your desk at work or throw one into a suitcase when you travel.
The downside is that wrist monitors are much more challenging to use correctly and can give inaccurate readings if misused. While an upper arm monitor is more cumbersome, accuracy is what matters. Ask your doctor which one they prefer.
Cuff size
If you choose an upper arm monitor, consider the size of your arm. Most models are one-size-fits-all, but you may not get the most accurate readings if you have a particularly small or large arm. Measure the circumference of your arm with string and compare it to the cuff dimensions offered.
Some home blood pressure monitors will come with multiple sizes of cuffs or will have an option to select a cuff size when you buy.
Ease of use
It's essential to read the instructions carefully when you first unbox your home blood pressure monitor. Be sure you're following the manufacturer's advice about arm placement and sitting position. Some models take as little as 20 seconds to get a reading, while others may take a full minute.
Also, look into battery life. Some models are rechargeable, while others will require regular batteries that may or may not be included.
Accuracy
The Food and Drug Administration approves all home blood pressure monitors sold in the United States to have similar accuracy to clinical models. That said, if you're misusing your device, government approval won't matter.
The best thing to do is take your home blood pressure monitor with you on your next doctor's visit. Have your doctor watch you take a reading and compare the results to their own machine. They should be able to adjust any mistakes or answer any questions you have.
App integration
Some home blood pressure monitors contain wireless Bluetooth technology that will automatically send your readings to an app on your smartphone or tablet. This is an easy way to chart your progress over time. Some apps will even send this information directly to your doctor at an interval of your choosing.
Some of these apps are better than others. Most will require a learning curve. If the main person using the monitor isn't very tech-savvy, you may not need or may even want to avoid this feature.
Multiple users function
If more than one person is using your machine, look for a multiple users function. Models with this feature can easily switch between two or more people, saving a lot of counter space at home or suitcase space while traveling by combining machines.
Monitoring your blood pressure with a spouse, roommate or other loved one is also a great way to ensure accountability. It's vital to take your blood pressure as often as your doctor recommends.
Wrist home blood pressure monitors range from $15-$50. Be sure to check reviews and buy from a trusted brand. Low-end upper arm home blood pressure monitors are around $20-$40. Mid-range models with Bluetooth or wider cuff sizes are generally $50-$90. High-end models with advanced features will run you $90-$150.
How many of my past readings should a home blood pressure monitor store?
A. If your prospective model works with an app, it should offer unlimited storage for past readings on your smartphone or tablet. For models that store past readings solely on the machine itself, it depends. Are you diligent enough to write down each reading in a notebook every time? If not, you'll want a higher storage capacity for when you forget.
What are some tips to achieve an accurate reading?
A. Don't exercise, smoke or drink caffeine half an hour before your reading. Sit upright with your back supported, and your feet planted firmly on the ground. Try to measure your blood pressure at the same time each day. Closely follow manufacturer and doctor instructions about cuff or wrist placement.
Top home blood pressure monitor
Withings BPM Connect Blood Pressure Monitor
What you need to know: This is a convenient and comfortable monitor full of advanced features.
What you'll love: It connects to an app via Bluetooth and has a rechargeable battery that lasts for six months. It will also email your results to your doctor.
What you should consider: Data storage is not set up well for multiple people using the same machine.
Top home blood pressure monitor for the money
Omron Gold Upper Arm Blood Pressure Monitor
What you need to know: This is an easy-to-use monitor from the biggest brand in the industry.
What you'll love: It stores up to 120 readings for up to two users. The cuff fits larger arms, and it's compatible with Amazon Alexa devices.
What you should consider: The machine is bulky compared to others on the market.
Worth checking out
Greater Goods Blood Pressure Monitor
What you need to know: This blood pressure monitor comes with a comfortable cuff that is easily adjustable.
What you'll love: The display is big and bright, and the button to start and stop the machine is also large for convenience. It can store up to 60 readings for two people. You can use it either via batteries or the included wall plug.
What you should consider: The batteries don't last very long, and the monitor resets when you change them.
BestReviews spends thousands of hours researching, analyzing and testing products to recommend the best picks for most consumers. BestReviews and its newspaper partners may earn a commission if you purchase a product through one of our links.
Distributed by Tribune Content Agency, LLC.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
RECALL: Fish sold in Connecticut recalled by FDA due to bacteria concerns
BRIDGEPORT, Conn. (WTNH) — Salted Smoked Split Herring sold in Connecticut is being recalled by the Food and Drug Administration (FDA). Fungi concerns spark nationwide recall of Zicam and Orajel products The recalled fish was distributed to retail locations in New York, New Jersey and Connecticut. Experts say that the product has potential to be contaminated with a bacteria called Clostridium botulinum that can cause life-threatening illness or death. The product was likely to be repacked in deli-style or other retail packaging. The fish is sold at Food Bazaar Supermarket in Bridgeport. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
14 hours ago
- Yahoo
Lawmakers urge Trump administration to clamp down on illicit GLP-1 sales
A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing these drugs without knowing the product could be fraudulent. North Carolina Reps. Brad Knott (R) and Deborah Ross (D) wrote to Food and Drug Administration (FDA) Commissioner Marty Makary, Homeland Security Secretary Kristi Noem and Attorney General Pam Bondi, imploring them to end the sale of 'counterfeit, research-grade and illegal copycats' of popular GLP-1 medications. When the commercial, branded versions of tirzepatide and semaglutide were declared to no longer be in shortage, compounding pharmacies were disallowed from continuing to sell compounded versions of those drugs. While telehealth companies have transitioned away from compounded versions, state officials have warned that 'copycat' drugs have proliferated in the months since the shortages ended. Earlier this year, the National Association of Attorneys General sent a letter to the FDA to warn that 'counterfeit GLP-1 drugs have infiltrated the U.S. supply chain from China, Turkey, India, and other foreign sources.' According to the attorneys general, online retailers sell the active ingredient for the GLP-1s under the claim that they're 'for research purposes only' or 'not for human consumption' while still marketing them to consumers on social media. The FDA issued a warning in April, telling consumers to not take counterfeit Ozempic. The drug's manufacturer, Novo Nordisk, had alerted the agency that several hundred units of counterfeit product had entered the U.S. supply chain. At the time, the FDA said it was aware of six adverse events associated with the counterfeit products. Though the FBI issued a public service warning soon after the letter from the attorneys general was sent, Knott and Ross said raising public awareness wasn't enough. 'FDA has received hundreds of reports of adverse events, even some resulting in the hospitalization and death of patients who used illicit GLP-1s,' they wrote. 'This is likely a significant underreporting of adverse events experienced by patients because federal law does not require state-licensed pharmacies that are not outsourcing facilities to submit adverse events to FDA.' The lawmakers asked that the Trump Cabinet members fully use 'the legal tools at your discretion' to further detect illicit and enforce U.S. drug standards. Sen. Thom Tillis (R-N.C.) sent his own letter to Cabinet members, calling for enhanced collaboration among agencies like FDA, U.S. Customs and Border Protection and the Justice Department in order to stop the counterfeit products from reaching the supply chain in the first place. The Hill has reached out to the agencies named in the letter for comment. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Chicago Tribune
15 hours ago
- Chicago Tribune
RFK Jr. names 8 vaccine committee replacements, including COVID shot critic
NEW YORK — U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. They include a scientist who researched mRNA vaccine technology and transformed into a conservative darling for his criticisms of COVID-19 vaccines, and a leading critic of pandemic-era lockdowns. Kennedy's decision to 'retire' the previous 17-member panel was widely decried by doctors' groups and public health organizations, who feared the advisers would be replaced by a group aligned with Kennedy's desire to reassess — and possibly end — longstanding vaccination recommendations. The new appointees to the Advisory Committee on Immunization Practices include Dr. Robert Malone, the former mRNA researcher who emerged as a close adviser to Kennedy during the measles outbreak. Malone, who runs a wellness institute and a popular blog, rose to popularity during the COVID-19 pandemic as he relayed conspiracy theories around the outbreak and the vaccines that followed. He has appeared on podcasts and other conservative news outlets where he's promoted unproven and alternative treatments for measles and COVID-19. He has claimed that millions of Americans were hypnotized into taking the COVID-19 shots. He's even suggested that those vaccines cause a form of AIDS. He's downplayed deaths related to one of the largest measles outbreaks in the U.S. in years. Other appointees include Dr. Martin Kulldorff, a biostatistician and epidemiologist who was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm. Dr. Cody Meissner, a former ACIP member, also was named. Kennedy made the announcement in a social media post on Wednesday. The committee, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention. CDC directors almost always approve those recommendations on how Food and Drug Administration-cleared vaccines should be used. The CDC's final recommendations are widely heeded by doctors and determine the scope of vaccination programs.